07-06-2020Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing
07-01-2020Please note: Currently, there is no possibility to purchase shares of CureVac AG. Offers to purchase shares in CureVac AG are fraudulent.
06-17-2020CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate
05-14-2020CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
03-16-2020CureVac announces leadership update
03-15-2020CureVac focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide